are there any natural glp-1 agonists America's Poison Centers npj Metabolic Health and Disease

136 DPP4 Inhibitors and COVID-19 Based on the factors mentioned, it has been proposed that DPP4 inhibitors could be beneficial for COVID-19 patients, potentially by preventing the entry of the virus

In addition to regulating blood sugar and lowering body weight in non-diabetic obese patients, tirzepatide can also lower liver fat and improve kidney outcomes (Rosenstock et al., 2025)

c) Kidney Protection By improving blood flow and reducing inflammation, GLP-1 drugs can delay diabetic kidney disease progression

Common side effects include nausea, vomiting, and diarrhea, but they are generally well-tolerated and tend to improve over time

doi: 10.1136/bmj-2023-076410

For patients, these cost saving measures can feel frustrating and counterproductive